Astroglia in dementia and Alzheimer's disease

Cell Death and Differentiation

Volumn 16, Issue 3, 2009, Pages 378-385

  Rodriguez J J ^a,b   Olabarria, M ^a   Chvatal, A ^b   Verkhratsky, A ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ASTROCYTE; ASTROCYTOSIS; BLOOD BRAIN BARRIER; BRAIN ATROPHY; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DISEASE COURSE; DISEASE MODEL; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; MACROGLIA; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRANSGENIC ANIMAL;

ALZHEIMER DISEASE; ANIMALS; ASTROCYTES; DEMENTIA; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HUMANS; MICE; MICE, TRANSGENIC;

EID: 60849109489     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2008.172     Document Type: Review

References (91)

1. Deiters O. Untersuchungen über Gehirn und Rückenmark des Menschen und der Säugethiere. Braunschweig: Vieweg, 1865.
2. Lenhossek Mv. Der feinere Bau des Nervensystems im Lichte neuester Forschung. Fischer's Medicinische Buchhandlung H Kornfield: Berlin, 1893.
3. Kettenmann H, Ransom BR. The concept of neuroglia: A historical perspective. In: Kettenmann H, Ransom BR (eds). Neuroglia. OUP: Oxford, 2005, pp 1-16.
4. Verkhratsky A. Patching the glia reveals the functional organisation of the brain. Pflugers Arch 2006; 453: 411-420.
5. Verkhratsky A, Butt A. Glial Neurobiology A text book. John Wiley & Sons: Chichester, 2007.
6. Giaume C, Kirchhoff F, Matute C, Reichenbach A, Verkhratsky A. Glia: The fulcrum of brain diseases. Cell Death Differ 2007; 14: 1324-1335.
7. Porter JT, McCarthy KD. Astrocytic neurotransmitter receptors in situ and in vivo. Prog Neurobiol 1997; 51: 439-455.
8. Verkhratsky A, Steinhauser C. Ion channels in glial cells. Brain Res Brain Res Rev 2000; 32: 380-412.
9. Verkhratsky A, Kirchhoff F. Glutamate-mediated neuronal-glial transmission. J Anat 2007; 210: 651-660.
10. Verkhratsky A. Calcium ions and integration in neural circuits. Acta Physiol (Oxf) 2006; 187: 357-369.
11. Dermietzel R, Gao Y, Scemes E, Vieira D, Urban M, Kremer M et al. Connexin43 null mice reveal that astrocytes express multiple connexins. Brain Res Brain Res Rev 2000; 32: 45-56.
12. Giaume C, McCarthy KD. Control of gap-junctional communication in astrocytic networks. Trends Neurosci 1996; 19: 319-325.
13. Volterra A, Meldolesi J. Astrocytes, from brain glue to communication elements: The revolution continues. Nat Rev Neurosci 2005; 6 626-640.
14. Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: Redefining the functional architecture of the brain. Trends Neurosci 2003; 26: 523-530.
15. Bushong EA, Martone ME, Jones YZ, Ellisman MH. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci 2002; 22: 183-192.
16. Oberheim NA, Wang X, Goldman S, Nedergaard M. Astrocytic complexity distinguishes the human brain. Trends Neurosci 2006; 29: 547-553.
17. Mulligan SJ, MacVicar BA. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 2004; 431: 195-199.
18. Zonta M, Angulo MC, Gobbo S, Rosengarten B, Hossmann KA, Pozzan T et al. Neuron-toastrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 2003; 6: 43-50.
19. Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci 2007; 10: 1369-1376.
20. Houades V, Koulakoff A, Ezan P, Seif I, Giaume C. Gap junction-mediated astrocytic networks in the mouse barrel cortex. J Neurosci 2008; 28: 5207-5217.
21. Scemes E, Giaume C. Astrocyte calcium waves: What they are and what they do. Glia 2006; 54: 716-725.
22. Kang J, Kang N, Lovatt D, Torres A, Zhao Z, Lin J et al. Connexin 43 hemichannels are permeable to ATP. J Neurosci 2008; 28: 4702-4711.
23. Tabernero A, Medina JM, Giaume C. Glucose metabolism and proliferation in glia: Role of astrocytic gap junctions. J Neurochem 2006; 99 1049-1061.
24. Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ. Glutamate induces calcium waves in cultured astrocytes: Long-range glial signaling. Science 1990; 247: 470-473.
25. Verkhratsky A, Orkand RK, Kettenmann H. Glial calcium: Homeostasis and signaling function. Physiol Rev 1998; 78: 99-141.
26. Verkhratsky A, Toescu EC. Neuronal-glial networks as substrate for CNS integration. J Cell Mol Med 2006; 10: 826-836.
27. Nedergaard M. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 1994; 263: 1768-1771.
28. Pakhotin P, Verkhratsky A. Electrical synapses between Bergmann glial cells and Purkinje neurones in rat cerebellar slices. Mol Cell Neurosci 2005; 28: 79-84.
29. Halassa MM, Fellin T, Haydon PG. The tripartite synapse: Roles for gliotransmission in health and disease. Trends Mol Med 2007; 13 54-63.
30. Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: Glia, the unacknowledged partner. Trends Neurosci 1999; 22: 208-215.
31. Lin SC, Bergles DE. Synaptic signaling between neurons and glia. Glia 2004; 47: 290-298.
32. Jabs R, Pivneva T, Huttmann K, Wyczynski A, Nolte C, Kettenmann H et al. Synaptic transmission onto hippocampal glial cells with hGFAP promoter activity. J Cell Sci 2005; 118: 3791-3803.
33. Panickar KS, Norenberg MD. Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia 2005; 50: 287-298.
34. Kofuji P, Newman EA. Potassium buffering in the central nervous system. Neuroscience 2004; 129: 1045-1056.
35. Danbolt NC. Glutamate uptake. Progr Neurobiol 2001; 65: 1-105.
36. Kirischuk S, Kettenmann H, Verkhratsky A. Membrane currents and cytoplasmic sodium transients generated by glutamate transport in Bergmann glial cells. Pflugers Arch 2007; 454: 245-252.
37. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol 2000; 62: 649-671.
38. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005; 50: 427-434.
39. Butt AM, Hamilton N, Hubbard P, Pugh M, Ibrahim M. Synantocytes: The fifth element. J Anat 2005; 207: 695-706.
40. Pekny M, Wilhelmsson U, Bogestal YR, Pekna M. The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 2007; 82: 95-111.
41. Broe M, Kril J, Halliday GM. Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. Brain 2004; 127 2214-2220.
42. Kersaitis C, Halliday GM, Kril JJ. Regional and cellular pathology in frontotemporal dementia: Relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol 2004; 108: 515-523.
43. Potts R, Leech RW. Thalamic dementia: An example of primary astroglial dystrophy of Seitelberger. Clin Neuropathol 2005; 24: 271-275.
44. Vanzani MC, Iacono RF, Caccuri RL, Troncoso AR, Berria MI. Regional differences in astrocyte activation in HIV-associated dementia. Medicina (B Aires) 2006; 66: 108-112.
45. Deshpande M, Zheng J, Borgmann K, Persidsky R, Wu L, Schellpeper C et al. Role of activated astrocytes in neuronal damage: Potential links to HIV-1-associated dementia. Neurotox Res 2005; 7: 183-192.
46. Nardacci R, Antinori A, Kroemer G, Piacentini M. Cell death mechanisms in HIV-associated dementia: The involvement of syncytia. Cell Death Differ 2005; 12 (Suppl 1): 855-858.
47. Thompson KA, McArthur JC, Wesselingh SL. Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann Neurol 2001; 49: 745-752.
48. Alzheimer A. ber eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiat Psych-Gericht Med 1907; 64: 146-148.
49. Thompson PM, Hayashi KM, Dutton RA, Chiang MC, Leow AD, Sowell ER et al. Tracking Alzheimer's disease. Ann N Y Acad Sci 2007; 1097: 183-214.
50. Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 2003; 23: 994-1005.
51. Alzheimer A. Beiträge zur Kenntnis der pathologischen Neuroglia und ihrer Beziehungen zu den Abbauvorgängen im Nervengewebe. In: Nissl F, Alzheimer A (eds). Histologische und histopathologische Arbeiten über die Grosshirnrinde mit besonderer Berücksichtigung der pathologischen Anatomie der Geisteskrankheiten. Gustav Fischer: Jena, 1910, pp 401-562.
52. DeWitt DA, Perry G, Cohen M, Doller C, Silver J. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp Neurol 1998; 149: 329-340.
53. Abramov AY, Canevari L, Duchen MR. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J Neurosci 2003; 23: 5088-5095.
54. Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging 2004; 25: 663-674.
55. Nagele RG, D'Andrea MR, Lee H, Venkataraman V, Wang HY. Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res 2003; 971: 197-209.
56. Toledano A, Alvarez MI. Lesions and dysfunctions of the nucleus basalis as Alzheimer's disease models: General and critical overview and analysis of the long-term changes in several excitotoxic models. Curr Alzheimer Res 2004; 189: 214.
57. Cassel JC, Mathis C, Majchrzak M, Moreau PH, Dalrymple-Alford JC. Coexisting cholinergic and parahippocampal degeneration: A key to memory loss in dementia and a challenge for transgenic models? Neurodegener Dis 2008; 5: 304-317.
58. Gotz J, Streffer JR, David D, Schild A, Hoerndli F, Pennanen L et al Transgenic animal models of Alzheimer's disease and related disorders: Histopathology, behavior and therapy. Mol Psychiatry 2004; 9: 664-683.
59. Biegon A, Greenberger V, Segal M. Quantitative histochemistry of brain acetylcholinesterase and learning rate in the aged rat. Neurobiol Aging 1986; 7: 215-217.
60. Bertoni-Freddari C, Giuli C, Pieri C, Paci D. Quantitative investigation of the morphological plasticity of synaptic junctions in rat dentate gyrus during aging. Brain Res 1986; 366: 187-192.
61. Sani S, Traul D, Klink A, Niaraki N, Gonzalo-Ruiz A, Wu CK et al. Distribution, progression and chemical composition of cortical amyloid-beta deposits in aged rhesus monkeys: Similarities to the human. Acta Neuropathol 2003; 105: 145-156.
62. Bartus RT, Dean III RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217: 408-414.
63. Pepeu G, Marconcini Pepeu I. Dysfunction of the brain cholinergic system during aging and after lesions of the nucleus basalis of Meynert. J Neural Transm Suppl 1994; 44: 189-194.
64. Wellman CL, Pelleymounter MA. Differential effects of nucleus basalis lesions in young adult and aging rats. Neurobiol Aging 1999; 20 381-393.
65. Wiley RG. Neural lesioning with ribosome-inactivating proteins: Suicide transport and immunolesioning. Trends Neurosci 1992; 15: 285-290.
66. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 1995; 373: 523-527.
67. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S et al Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996; 274: 99-102.
68. Arendash GW, Lewis J, Leighty RE, McGowan E, Cracchiolo JR, Hutton M et al. Multimetric behavioral comparison of APPsw and P301L models for Alzheimer's disease: Linkage of poorer cognitive performance to tau pathology in forebrain. Brain Res 2004; 1012: 29-41.
69. Galvan V, Zhang J, Gorostiza OF, Banwait S, Huang W, Ataie M et al Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664. Behav Brain Res 2008; 191: 246-255.
70. Gruart A, Lopez-Ramos JC, Munoz MD, Delgado-Garcia JM. Aged wild-type and APP, PS1, and APP+PS1 mice present similar deficits in associative learning and synaptic plasticity independent of amyloid load. Neurobiol Dis 2008; 30: 439-450.
71. Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP et al Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: Relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis 2005; 18: 602-617.
72. Dodart JC, Mathis C, Saura J, Bales KR, Paul SM, Ungerer A. Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice. Neurobiol Dis 2000; 7: 71-85.
73. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD et al A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000; 408: 979-982.
74. Schindowski K, Bretteville A, Leroy K, Begard S, Brion JP, Hamdane M et al. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 2006; 169: 599-616.
75. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R et al Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 2003; 39: 409-421.
76. Brendza RP, Bales KR, Paul SM, Holtzman DM. Role of apoE/Abeta interactions in Alzheimer's disease: Insights from transgenic mouse models. Mol Psychiatry 2002; 7: 132-135.
77. Gotz J, Probst A, Spillantini MG, Schafer T, Jakes R, Burki K et al Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J 1995; 14: 1304-1313.
78. Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 2000; 25: 402-405.
79. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 2003; 24: 1063-1070.
80. McKee AC, Carreras I, Hossain L, Ryu H, Klein WL, Oddo S et al. Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice. Brain Res 2008; 1207: 225-236.
81. Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 2007; 27: 13357-13365.
82. Rodriguez JJ, Mackie K, Pickel VM. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. J Neurosci 2001; 21: 823-833.
83. Chvatal A, Anderova M, Kirchhoff F. Three-dimensional confocal morphometry - a new approach for studying dynamic changes in cell morphology in brain slices. J Anat 2007; 210: 671-683.
84. Chvatal A, Anderova M, Hock M, Prajerova I, Neprasova H, Chvatal V et al. Three-dimensional confocal morphometry reveals structural changes in astrocyte morphology in situ. J Neurosci Res 2007; 85: 260-271.
85. Senitz D, Reichenbach A, Smith Jr TG. Surface complexity of human neocortical astrocytic cells: Changes with development, aging, and dementia. J Hirnforsch 1995; 36: 531-537.
86. Léveillé F, Ortega JB, Rodríguez JJ, Meadows RS, Verkhratsky A, Nicole O et al. Increase in excitatory synapses density and functional modification of NMDA receptors-mediated responses induced by β-amyloid oligomers. Unpublished observations.
87. Rodríguez JJ, Jones VC, Tabuchi M, Allan SM, Knight EM, LaFerla FM et al. Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease. PLOS One 2008; 3 e2935.
88. Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J et al. An astrocytic basis of epilepsy. Nat Med 2005; 11: 973-981.
89. Nedergaard M, Dirnagl U. Role of glial cells in cerebral ischemia. Glia 2005; 50: 281-286.
90. Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007; 68: 1501-1508.
91. Terry RD. Cell death or synaptic loss in Alzheimer disease. J Neuropathol Exp Neurol 2000; 59: 1118-1119.